Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8977852 | 0.74 | CHEK1 (0.34) | ALDH1A1L3MBTL1 | |
| SCHEMBL14672809 | 0.74 | KMT2A (0.33) | ALDH1A1L3MBTL1 | |
| SCHEMBL3209050 | 0.74 | CYP11B2 (0.37) | ALDH1A1CYP11B2L3MBTL1 | |
| SCHEMBL18078709 | 0.69 | EGLN2 (0.53) | ALDH1A1 | |
| SCHEMBL7915878 | 0.69 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1 | |
| SCHEMBL9769233 | 0.67 | KMT2A (0.33) | ALDH1A1 | |
| SCHEMBL9769333 | 0.66 | TSHR (0.31) | — | |
| SCHEMBL1187776 | 0.66 | — | — | |
| SCHEMBL3303841 | 0.65 | AHR (0.58) | AHRCYP11B2 | |
| SCHEMBL18077056 | 0.65 | EGLN2 (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100047321-A1 | SILVER ANTIMICROBIAL COMPOSITION AND USE | EASTMAN KODAK COMPANY | 2010-02-25 | — | — | US | claimed |
| WO-2010021662-A2 | SILVER ANTIMICROBIAL COMPOSITION AND USE | EASTMAN KODAK COMPANY (US) | 2010-02-25 | — | — | WO | claimed |
| US-20110293683-A1 | Silver antimicrobial composition with extended shelf-life | CERION TECHNOLOGY, INC. | 2011-12-01 | — | — | US | disclosed |
| US-20100047321-A1 | SILVER ANTIMICROBIAL COMPOSITION AND USE | EASTMAN KODAK COMPANY | 2010-02-25 | — | — | US | disclosed |
| WO-2010021662-A2 | SILVER ANTIMICROBIAL COMPOSITION AND USE | EASTMAN KODAK COMPANY (US) | 2010-02-25 | — | — | WO | disclosed |
| EP-1173170-A4 | PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO INC (US) | 2002-05-29 | — | — | EP | disclosed |
| EP-1173170-A1 | PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Merck & Co., Inc. (US) | 2002-01-23 | — | — | EP | disclosed |
| US-6265434-B1 | ANTIINFLAMMATORY AGENTS | MERCK & CO., INC. | 2001-07-24 | — | — | US | disclosed |
| WO-2000059503-A1 | PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | MERCK & CO., INC. (US) | 2000-10-12 | — | — | WO | disclosed |
| US-5210014-A | Benzimidazole carbocyanine dyes, storage stability | EASTMAN KODAK COMPANY (US) | 1993-05-11 | — | — | US | disclosed |
| EP-0506077-A1 | Mid-green sensitizing dyes for photographic materials | EASTMAN KODAK COMPANY (US) | 1992-09-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110293683-A1 | Silver antimicrobial composition with extended shelf-life | AMPD1, GMPS, GDA | AHR 791/4885ALDH1A1 200/4885CYP11B2 4422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.